Assessing Hawkins (HWKN) Valuation With A Premium P/E And Mixed Signals From DCF

Hawkins, Inc.

Hawkins, Inc.

HWKN

0.00

Recent share performance and business mix

With no single headline event driving Hawkins (HWKN) today, the stock’s recent performance and business mix are taking center stage as investors reassess a US$3.2b chemicals and water treatment company with three distinct segments.

At a share price of US$153.14, Hawkins has given investors a 5.4% year to date share price return and a 19.8% total shareholder return over the past year, with short term momentum softening compared with very strong multi year gains.

If Hawkins’s run has you thinking about what else is out there, this could be a good moment to broaden your search and check out the 20 top founder-led companies

So with Hawkins now a US$3.2b pure play on US water treatment and specialty ingredients, are you looking at a stock that still trades at a discount, or has the market already priced in its future growth potential?

Price-to-earnings of 39.2x: Is it justified?

At the last close of $153.14, Hawkins trades on a P/E of 39.2x, which screens as expensive compared with both its own fair ratio and the wider chemicals peer group.

The P/E multiple compares the current share price to earnings per share and is a quick way to see how much investors are paying for each dollar of profit. For a chemicals and water treatment business like Hawkins, a higher P/E can sometimes reflect confidence in consistent earnings, but it can also indicate that expectations are already demanding at today’s price.

Here, Hawkins’s 39.2x P/E sits well above the estimated fair P/E of 18.7x. This suggests the market is paying a premium relative to where the SWS fair ratio model indicates it could settle over time. It is also higher than the US chemicals industry average P/E of 27x and the peer average of 24.2x. This points to investors assigning Hawkins a richer valuation than many close comparables.

Result: Price-to-earnings of 39.2x (OVERVALUED)

However, the premium P/E leaves little room for disappointment, and any slowdown in revenue or earnings growth could quickly challenge confidence in today’s valuation.

Another view on Hawkins’ valuation

While the current 39.2x P/E screens as expensive, the SWS DCF model paints a slightly different picture. On this view, Hawkins’ estimated future cash flow value sits at $138.76 per share, with the stock trading at $153.14. This points to a more modest level of overvaluation than the earnings multiple suggests. Which lens should investors consider more carefully when thinking about risk at today’s price?

HWKN Discounted Cash Flow as at May 2026
HWKN Discounted Cash Flow as at May 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Hawkins for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed signals so far leave you unsure, that is a useful starting point. Take a closer look at both sides of the story by weighing the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If Hawkins has sharpened your focus, do not stop here. Broaden your watchlist now so you are not relying on a single stock story.

  • Target long term value hunters by scanning for quality companies trading below estimated worth with the 49 high quality undervalued stocks.
  • Lock in potential income ideas by focusing on companies with robust payouts using the 10 dividend fortresses.
  • Reduce portfolio stress by filtering for companies with resilient finances through the 66 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.